Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

ClinicalTrials.gov ID: NCT00808132

Public ClinicalTrials.gov record NCT00808132. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo And Active- Controlled Efficacy And Safety Study Of The Effects Of Bazedoxifene/Conjugated Estrogens Combinations On Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to evaluate the safety and effectiveness of this investigational drug for the treatment of menopausal symptoms while protecting the endometrium (uterine lining) and preventing postmenopausal osteoporosis. Subject participation will last approximately 14.5 months.

Study identification

NCT ID
NCT00808132
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,886 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 64 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2009 (Type not available)
Primary completion
Feb 2011 (Actual)
Completion
Feb 2011 (Actual)
Last update posted
Apr 8, 2014

2009 – 2011

United States locations

U.S. sites
143
U.S. states
37
U.S. cities
122
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35235 —
Pfizer Investigational Site Mobile Alabama 36608 —
Pfizer Investigational Site Chandler Arizona 85225 —
Pfizer Investigational Site Glendale Arizona 85308 —
Pfizer Investigational Site Mesa Arizona 85206 —
Pfizer Investigational Site Peoria Arizona 85381 —
Pfizer Investigational Site Phoenix Arizona 85032 —
Pfizer Investigational Site Scottsdale Arizona 85251 —
Pfizer Investigational Site Tucson Arizona 85710 —
Pfizer Investigational Site Tucson Arizona 85712 —
Pfizer Investigational Site Tucson Arizona 85715 —
Pfizer Investigational Site Little Rock Arkansas 72223 —
Pfizer Investigational Site Carmichael California 95608 —
Pfizer Investigational Site Sacramento California 95821 —
Pfizer Investigational Site San Diego California 92103 —
Pfizer Investigational Site San Diego California 92108 —
Pfizer Investigational Site San Diego California 92123 —
Pfizer Investigational Site Upland California 91786 —
Pfizer Investigational Site Vista California 92083 —
Pfizer Investigational Site Walnut Creek California 94598 —
Pfizer Investigational Site Colorado Springs Colorado 80907 —
Pfizer Investigational Site Colorado Springs Colorado 80910 —
Pfizer Investigational Site Denver Colorado 80218 —
Pfizer Investigational Site Denver Colorado 80220 —
Pfizer Investigational Site Lakewood Colorado 80228 —
Pfizer Investigational Site New London Connecticut 06320 —
Pfizer Investigational Site Boynton Beach Florida 33472 —
Pfizer Investigational Site Clearwater Florida 33759 —
Pfizer Investigational Site Crystal River Florida 34429 —
Pfizer Investigational Site Daytona Beach Florida 32114 —
Pfizer Investigational Site DeLand Florida 32720 —
Pfizer Investigational Site Fort Lauderdale Florida 33316 —
Pfizer Investigational Site Fort Lauderdale Florida 33328 —
Pfizer Investigational Site Fort Myers Florida 33916 —
Pfizer Investigational Site Lake Worth Florida 33461 —
Pfizer Investigational Site Miami Florida 33143 —
Pfizer Investigational Site Miami Florida 33169 —
Pfizer Investigational Site Miami Springs Florida 33166 —
Pfizer Investigational Site New Port Richey Florida 34652 —
Pfizer Investigational Site Pinellas Park Florida 33781 —
Pfizer Investigational Site Sunrise Florida 33323 —
Pfizer Investigational Site Tampa Florida 33606 —
Pfizer Investigational Site Vero Beach Florida 32960 —
Pfizer Investigational Site Atlanta Georgia 30342 —
Pfizer Investigational Site Augusta Georgia 30909 —
Pfizer Investigational Site Decatur Georgia 30033 —
Pfizer Investigational Site Decatur Georgia 30319 —
Pfizer Investigational Site Savannah Georgia 31405 —
Pfizer Investigational Site Savannah Georgia 31406 —
Pfizer Investigational Site Boise Idaho 83702 —
Pfizer Investigational Site Idaho Falls Idaho 83404 —
Pfizer Investigational Site Meridian Idaho 83642 —
Pfizer Investigational Site Chicago Illinois 60610 —
Pfizer Investigational Site Rockford Illinois 61107 —
Pfizer Investigational Site South Bend Indiana 46601 —
Pfizer Investigational Site Overland Park Kansas 66210 —
Pfizer Investigational Site Lexington Kentucky 40536-0293 —
Pfizer Investigational Site Lousiville Kentucky 40291 —
Pfizer Investigational Site Bangor Maine 4401 —
Pfizer Investigational Site Ann Arbor Michigan 48106 —
Pfizer Investigational Site Kalamazoo Michigan 49009 —
Pfizer Investigational Site Paw Paw Michigan 49079 —
Pfizer Investigational Site Saginaw Michigan 48604 —
Pfizer Investigational Site Southfield Michigan 48034 —
Pfizer Investigational Site Brooklyn Center Minnesota 55430 —
Pfizer Investigational Site Chaska Minnesota 55318 —
Pfizer Investigational Site Robbinsdale Minnesota 55422 —
Pfizer Investigational Site St Louis Missouri 63131 —
Pfizer Investigational Site Billings Montana 59101 —
Pfizer Investigational Site Billings Montana 59102 —
Pfizer Investigational Site Lincoln Nebraska 68510 —
Pfizer Investigational Site Omaha Nebraska 68131 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Las Vegas Nevada 89146 —
Pfizer Investigational Site North Las Vegas Nevada 89030 —
Pfizer Investigational Site Reno Nevada 89502 —
Pfizer Investigational Site Lebanon New Hampshire 03756 —
Pfizer Investigational Site Brick New Jersey 08723 —
Pfizer Investigational Site New Brunswick New Jersey 08901 —
Pfizer Investigational Site Albuquerque New Mexico 87102 —
Pfizer Investigational Site Albuquerque New Mexico 87106 —
Pfizer Investigational Site New York New York 10032 —
Pfizer Investigational Site Port Jefferson New York 11777 —
Pfizer Investigational Site Charlotte North Carolina 29209 —
Pfizer Investigational Site Kernersville North Carolina 27284 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Bismarck North Dakota 58501 —
Pfizer Investigational Site Fargo North Dakota 58103 —
Pfizer Investigational Site Minot North Dakota 58701 —
Pfizer Investigational Site Akron Ohio 44311 —
Pfizer Investigational Site Cincinnati Ohio 45236 —
Pfizer Investigational Site Cleveland Ohio 44106-6010 —
Pfizer Investigational Site Cleveland Ohio 44122 —
Pfizer Investigational Site Columbus Ohio 43213 —
Pfizer Investigational Site Dayton Ohio 45439 —
Pfizer Investigational Site Englewood Ohio 45322 —
Pfizer Investigational Site Mayfield Heights Ohio 44124 —
Pfizer Investigational Site Eugene Oregon 97401 —
Pfizer Investigational Site Medford Oregon 97504 —
Pfizer Investigational Site Portland Oregon 97205 —
Pfizer Investigational Site Erie Pennsylvania 16502 —
Pfizer Investigational Site Hopwood Pennsylvania 15445 —
Pfizer Investigational Site Jenkintown Pennsylvania 19046 —
Pfizer Investigational Site Johnstown Pennsylvania 15905 —
Pfizer Investigational Site Philadelphia Pennsylvania 19104 —
Pfizer Investigational Site Philadelphia Pennsylvania 19114 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15206 —
Pfizer Investigational Site West Reading Pennsylvania 19611 —
Pfizer Investigational Site Wexford Pennsylvania 15090 —
Pfizer Investigational Site Warwick Rhode Island 02886 —
Pfizer Investigational Site Bluffton South Carolina 29910 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site Hilton Head Island South Carolina 29926 —
Pfizer Investigational Site Sioux Falls South Dakota 57104 —
Pfizer Investigational Site Sioux Falls South Dakota 57105 —
Pfizer Investigational Site Sioux Falls South Dakota 67105 —
Pfizer Investigational Site Watertown South Dakota 57201 —
Pfizer Investigational Site Chattanooga Tennessee 37404 —
Pfizer Investigational Site Jackson Tennessee 38305 —
Pfizer Investigational Site Knoxville Tennessee 37920 —
Pfizer Investigational Site Memphis Tennessee 38120 —
Pfizer Investigational Site Nashville Tennessee 37203 —
Pfizer Investigational Site Corpus Christi Texas 78414 —
Pfizer Investigational Site Dallas Texas 75390 —
Pfizer Investigational Site Denton Texas 76210 —
Pfizer Investigational Site Fort Worth Texas 76104 —
Pfizer Investigational Site Houston Texas 77030 —
Pfizer Investigational Site Irving Texas 75061 —
Pfizer Investigational Site Irving Texas 75062 —
Pfizer Investigational Site Plano Texas 75093 —
Pfizer Investigational Site San Antonio Texas 78154 —
Pfizer Investigational Site San Antonio Texas 78217 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Waco Texas 76712 —
Pfizer Investigational Site Pleasant Grove Utah 84062 —
Pfizer Investigational Site Salt Lake City Utah 84117 —
Pfizer Investigational Site Sandy City Utah 84070 —
Pfizer Investigational Site Charlottesville Virginia 22903 —
Pfizer Investigational Site Norfolk Virginia 23502 —
Pfizer Investigational Site Norfolk Virginia 23507 —
Pfizer Investigational Site Richmond Virginia 23294 —
Pfizer Investigational Site Seattle Washington 98105 —
Pfizer Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00808132, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00808132 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →